Skip to content
Clear Collective UK

Zimbabwe Rejects ‘One-Sided’ US Healthcare Assistance Deal Over Information Fears

Health funding image
The offered US funding would have supported initiatives for treating and preventing HIV/Aids, TB, and malarial diseases.

Zimbabwe has declined a substantial American healthcare agreement valued at 367 million US dollars (272 million pounds) spanning five years because of Washington's request for confidential information.

This rejection became public after a government memo dated December was leaked, indicating that Head of State Emmerson Mnangagwa felt the agreement was "lopsided".

A government representative later stated that the US was demanding access to health data for scientific study and commercial purposes but was not willing to guarantee the resulting advantages from any future treatments.

"We are forced to start the challenging and unfortunate process of winding down our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy indicated the United States had provided more than $1.9bn as health assistance to Zimbabwe over the last two decades.

A doctors' association in Zimbabwe has urged more dialogue to secure a deal suitable to all parties so the country's vital HIV programme can continue.

Broader Context

This rejection comes after a similar case in Kenya, where a court halted a related deal with the US following concerns were filed about the safety of Kenyans' health data.

Since returning to office last year, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).

USAID had overseen assistance for the US government, but Trump claimed its spending was "wasteful" and his administration was seeking direct bilateral deals to boost openness and responsibility.

Based on reports, Sixteen nations in Africa have to date signed similar health pacts, representing over $18.3bn in committed funds.

Details of the Rejected Deal

This assistance for Zimbabwe would have funded "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We are confident this collaboration would have delivered extraordinary benefits for Zimbabwean communities, particularly the 1.2 million presently on antiretroviral therapy through US-supported initiatives," the Ambassador said.

However, official spokesman Nick Mangwana maintained the proposed deal was "unfair".

"Our nation was requested to provide its biological resources and data for a long time, with no corresponding guarantee of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that might result from that provided information," his statement read.

"In essence, our nation would supply the basic resources for scientific discovery with no certainty that the resulting innovations would be available to our population if a future disease outbreak arise."

Sovereignty and International Frameworks

Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one deals were undermining systems previously established via the global health agency.

The spokesperson gave as an example its Pandemic Benefit-Sharing system designed to manage future global health emergencies.

"This framework is intended to guarantee that when a nation provides its data, the resulting advantages – such as vaccines and treatments – are distributed fairly, not monopolised solely by those with the capability to create them."

These objections over the US deal "are not meant as opposition to America," Mangwana stressed.

"We welcome further dialogue with our US partners on how subsequent co-operation could be designed in a way that honours the sovereignty and dignity of both nations."

Health Experts Reaction

A leading public health body stated it recognised the government's concerns, but suggested that talks need to persist considering a large portion of the country's Aids initiatives were funded by external financing.

"If technical issues arise, such as those involving information security or agreement terms, these can often be addressed through detailed discussion and negotiated safeguards," the group said.

The halted deal emphasises the complex tensions between accepting crucial foreign assistance and safeguarding national sovereignty in an ever more interconnected world.

AR
Written by

Andrea Rivers

Eleanor Vance is a writer and researcher focused on clarity and collaborative wisdom.

Clear Collective UK

Type to search articles.